are a common condition in Southeast Asian countries. However, fears that the therapy could adversely interact with the Covid vaccination appear to be unfounded. Credit: YJ Hua/Sun Yat-sen University Cancer Center A clinical trial on nasopharyngeal cancer with an unexpected outcome. Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system …
Results from the STOP-COVID trial presented at ERS 2022 showed no clinical benefit with the dipeptidyl peptidase-1 (DPP-1) inhibitor brensocatib compared to placebo in patients hospitalized with COVID-19 in the UK. “[T]retreatment with brensocatib for 28 days was associated with worse clinical status on the WHO 7-point ordinal scale* at the end of treatment than …
September 29, 2022 2 min reading Source/Disclosure Disclosure: Montani reports that the institution receives grants or contracts from Acceleron, Janssen, and Merck; consulting fees from Acceleron; and honoraria from Bayer, Janssen, and Merck. Please see the study for all the relevant financial data of the other authors. ADD SUBJECT TO EMAIL NOTIFICATIONS Receive an email …
COVID-19 leads to high in-hospital mortality in patients with pulmonary hypertension Read More »
Deloitte Canada would have moved into the newly opened Vancouver office sooner if not for the pandemic. However, the delay gave the company some time to consider how the space should be used. “We were able to really think about this ‘next normal,’” said Jayara Darras, head of corporate culture and people, which includes supporting …
In a recent study published on Research Square* Preprint server, Researchers examined gender differences among patients with coronavirus disease 2019 (COVID-19) in the United States (US). Study: Gender differences in the diagnosis of COVID-19, risk factors and disease comorbidities. Image credit: Kzenon/Shutterstock Studies report greater severity and mortality related to COVID-19 in men compared to …
Study reveals disparities in clinical outcomes of COVID-19 in the US based on gender Read More »
Soaring Covid-19 and flu infections will exacerbate staff shortages and transport problems as health experts warn the true number of virus cases may be more than twice as bad as they appear. While the death toll from covid has risen steadily since March, the perception that the disease is no longer as serious for younger …
Most research on SARS-CoV-2 immunity and COVID-19 vaccine development has focused on antibody responses to spike protein and other viral surface proteins. But antibodies that recognize the virus’s intrinsic proteins may also be important for immunity and disease outcomes, according to a new study by researchers at the University of Pittsburgh, the Georgia Institute of …
Antibody profiles of intrinsic viral proteins predict severe COVID-19 results Read More »
In a recent study published on medRxiv* prepress server, researchers evaluated the impact of modern causal inference methods in estimating the effect of corticosteroids on coronavirus disease-related mortality 2019 (COVID-19). Study: Corticosteroids in COVID-19: Optimization of observational research through target trial emulations. Image credit: luchschenF / Shutterstock Observational research has provided great opportunities to understand …
The effect of corticosteroids on mortality in hospitalized patients with COVID-19 Read More »
At the end of 2021, there was a worldwide recovery of coronavirus disease 2019 (COVID-19) due to the occurrence of highly transmissible acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant Omicron. Omicron surpassed the Delta variant by the end of December 2021. At the beginning of January, Omicron spread considerably around the world, even in places …
Having up-to-date information on COVID-19 vaccines means having three or four doses of the same dose at this time. The current boosters are the same formulations as the first permitted injections based on the original coronavirus strain, which appeared in late 2019. It still protects against serious COVID-19 disease, hospitalizations and deaths. But as immunity …
As Aotearoa New Zealand heads into the colder winter months, the pressure on our health system and staff is growing significantly. In addition to the continuing impact of COVID-19, flu cases have begun to rise. The conditions are also prepared for the potential outbreak of other diseases, including measles, pertussis and respiratory syncytial virus (RSV). …
Credit: Pixabay / CC0 Public Domain Influenza regulation for medical staff is ethically justified, but the same cannot be said for vaccination against COVID-19, say leading ethics in an extended essay published online at Journal of Medical Ethics. Unlike COVID-19 vaccination, the advantages outweigh the disadvantages for all age groups: influenza vaccination is safe and …
Regulation against influenza, but not on COVID-19, ethically justified for medical staff Read More »
